PDCD1 and neoplasm: When PD-L1 on tumor cells binds to its cognate inhibitory receptor PD-1 expressed on tumor-infiltrating lymphocytes (TILs), the inhibitory signaling pathway induced by PD-L1 negatively regulates T-cell activation and proliferation, promoting T cell exhaustion 30.